Insoluble wild–type and protease–resistant mutant prion protein in brains of patients with inherited prion disease
- 1 January 1996
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 2 (1), 59-64
- https://doi.org/10.1038/nm0196-59
Abstract
We studied prion proteins (PrP) in skin and brains of Libyan Jews carrying the E200K mutation who died of familial Creutzfeldt-Jakob disease (CJD). Unexpectedly, studies with brain showed that PrP molecules encoded both by the wild-type (wt) and mutant alleles exhibit altered properties characteristic of the prion protein associated with prion diseases (PrPSc). Using monospecific antisera, we found that wtPrP was insoluble in the brains of three patients who were heterozygous for the E200K mutation, whereas mutant PrP was both insoluble and protease-resistant. Our results argue that both wild-type and mutant PrP undergo conformational changes and are particularly intriguing, because the normal isoform PrPc is soluble in nondenaturing detergents and is readily digested by proteases, whereas PrPSc is insoluble and resistant to proteolytic digestion. Our findings indicate that insoluble wtPrP represents a conformational intermediate, the first to be identified, within a pathway in which PrPc is converted to PrPSc.Keywords
This publication has 40 references indexed in Scilit:
- Prion Protein Peptides Induce .alpha.-Helix to .beta.-Sheet Conformational TransitionsBiochemistry, 1995
- Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish Kindreds) express only PrP peptides encoded by the mutant alleleCell, 1994
- Counselling in general practice.BMJ, 1993
- Fatal Familial Insomnia and Familial Creutzfeldt-Jakob Disease: Disease Phenotype Determined by a DNA PolymorphismScience, 1992
- Mutation of the Prion Protein in Libyan Jews with Creutzfeldt–Jakob DiseaseNew England Journal of Medicine, 1991
- Chemoprophylaxis of scrapie in miceJournal of General Virology, 1991
- Intracellular accumulation of the cellular prion protein after mutagenesis of its Asnlinked glycosylation sitesGlycobiology, 1990
- Dextran Sulphate 500 Delays and Prevents Mouse Scrapie by Impairment of Agent Replication in SpleenJournal of General Virology, 1984
- The antiviral compound HPA-23 can prevent scrapie when administered at the time of infectionArchiv für die gesamte Virusforschung, 1983
- Creutzfeldt-Jakob Disease: Focus among Libyan Jews in IsraelScience, 1974